Millennium Management’s AnaptysBio ANAB Stock Holding History

Millennium Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,100	Closed	-$309K	–	5981
2025 Q3	$309K	Buy	+10,100	New	+$232K	﹤0.01%	5325
2021 Q2	–	Sell	-22,800	Closed	-$491K	–	6483
2021 Q1	$491K	Buy	+22,800	New	+$575K	﹤0.01%	4844
2020 Q1	–	Sell	-72,900	Closed	-$1.19M	–	3802
2019 Q4	$1.19M	Sell	72,900 -390,000	-84%	-$9.22M	﹤0.01%	2928
2019 Q3	$16.2M	Buy	+462,900	New	+$22M	0.03%	933
2018 Q3	–	Sell	-50,800	Closed	-$3.61M	–	3863
2018 Q2	$3.61M	Buy	+50,800	New	+$4.26M	﹤0.01%	2020

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management's ANAB Position: Q1 2026 in Review

Millennium Management reduced its AnaptysBio (ANAB) stake by 42% in Q1 2026, selling an estimated $18.2M and leaving 475,572 shares worth $26.4M. The position accounts for 0.01% of the portfolio, ranked #1318.

Millennium Management first reported a position in ANAB in Q1 2017 and has held it in 35 quarters since. The position peaked at $53M in Q2 2019. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Millennium Management held 475,572 shares of AnaptysBio worth $26.4M as of Q1 2026.
Millennium Management sold 337,999 AnaptysBio shares in Q1 2026, an estimated $18.2M.
AnaptysBio made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1318 holding.
Millennium Management first reported a position in AnaptysBio in Q1 2017 and has held it in 35 quarters since.
Millennium Management's AnaptysBio position peaked at $53M in Q2 2019.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.